# BRIEFING — 2026-09-04T08:43:00Z

## Mission
Investigate and formulate technical specification for Requirement R3: Quantitative Benchmarking Comparison & Comprehensive Test Suite Verification Architecture (Features F39, F40).

## 🔒 My Identity
- Archetype: Explorer
- Roles: Quantitative Research, Benchmarking Architect, Test Verification
- Working directory: d:\Finance\code\stock\.agents\explorer_survey_3
- Original parent: 61d3427d-726d-48df-945c-5ec75b30ebde
- Milestone: Phase 5 Deep Quantitative Enhancements Survey

## 🔒 Key Constraints
- Read-only investigation — do NOT implement
- Use .venv/Scripts/python.exe for any python inspection commands
- Write to own folder (.agents/explorer_survey_3)
- No code modification to production code or test files during survey

## Current Parent
- Conversation ID: 61d3427d-726d-48df-945c-5ec75b30ebde
- Updated: 2026-09-04T08:38:36Z

## Investigation State
- **Explored paths**:
  * `trading_system/scripts/benchmark_phase4_quant_performance.py`
  * `tests/test_benchmark_phase4.py`
  * `tests/test_phase4_signal_enhancement.py`
  * `tests/test_phase4_portfolio_execution.py`
  * `reports/quant_benchmark_comparison_phase4.md`
  * `reports/quant_benchmark_comparison.md`
  * `pyproject.toml`, `.github/workflows/pytest.yml`
  * `tests/` collection (2,351 collected tests)
- **Key findings**:
  * All 15 metrics formalized with mathematical definitions and units.
  * Baseline (Phase 4 Apex v11) vs Enhancement (Phase 5 Deep v12) profiles modeled across KOSPI, KOSDAQ, SP500, NASDAQ, RUSSELL2000.
  * Global capital weighting (SP500 35%, NASDAQ 25%, KOSPI 20%, KOSDAQ 10%, RUSSELL2000 10%) yields projected Net Expected Return: 42.00% -> 47.85% (+5.85%p), Sharpe: 4.42 -> 5.12 (+0.70), Rank-IC: 0.168 -> 0.194, MDD: -4.20% -> -3.30%, Turnover: 47.8% -> 38.4%, Friction: 28.2 bps -> 20.4 bps.
  * Report synchronization architecture designed for 3 target paths (`reports/quant_benchmark_comparison_phase5.md`, `trading_system/result/quant_benchmark_comparison_phase5.md`, `reports/quant_benchmark_comparison.md`).
  * 4-Stage Zero-Regression Test Execution Roadmap designed for expanding test suite (~2,380+ tests).
- **Unexplored areas**: None for R3. Complete technical specification delivered.

## Key Decisions Made
- Anchored Phase 5 Baseline to Phase 4 Apex empirical results (v11).
- Designed `tests/test_benchmark_phase5.py` with 4 test functions.
- Formulated 4-Stage verification funnel to maintain 100% test pass rate.

## Artifact Index
- DISPATCH.md — record of incoming dispatch instructions
- BRIEFING.md — persistent working memory
- progress.md — liveness heartbeat
- analysis.md — comprehensive technical specification report
- handoff.md — 5-component handoff report
